SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-24-002761
Filing Date
2024-04-29
Accepted
2024-04-29 08:00:33
Documents
17
Period of Report
2024-04-26
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT mosaic_8k.htm   iXBRL 8-K 30985
2 BINDING TERM SHEET DATED APRIL 26, 2024 mosaic_ex1001.htm EX-10.1 28183
3 PRESS RELEASE mosaic_ex9901.htm EX-99.1 13974
7 GRAPHIC image001.jpg GRAPHIC 11091
8 GRAPHIC image_001.jpg GRAPHIC 4751
  Complete submission text file 0001683168-24-002761.txt   274844

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE cpmv-20240426.xsd EX-101.SCH 3015
5 XBRL LABEL FILE cpmv-20240426_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE cpmv-20240426_pre.xml EX-101.PRE 22359
20 EXTRACTED XBRL INSTANCE DOCUMENT mosaic_8k_htm.xml XML 3240
Mailing Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646
Business Address 9114 ADAMS AVE. #202 HUNTINGTON BEACH CA 92646 657-208-0890
Mosaic ImmunoEngineering Inc. (Filer) CIK: 0000836564 (see all company filings)

IRS No.: 841070278 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-22182 | Film No.: 24886655
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)